Upper Gastrointestinal (GI) Series Market Research Report - Forecast to 2027

Global upper GI series market research report, by test types (the standard barium upper GI series & double-contrast upper GI series), by type of imaging material (barium swallow, barium meal, barium follow-through), by application (esophageal reflux, esophageal varices, ulcers, hiatal hernias & others), by end users (hospitals, clinics & laboratories and other) -Forecast till 2027

ID: MRFR/Pharma/0330-HCR | February 2021 | Region: Global | 146 pages

Please note that the assessment period of report has been updated from 2018-2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario:


An upper gastrointestinal (GI) series is also known as contrast radiography or upper gastrointestinal study, which is performed to detect abnormalities and diseases of GI tract. In this procedure, a contrast media is ingested or imparted into the digestive tract and X-rays are used to create radiographs of the desired portion. According to the National Institute of Diabetes and Digestive and Kidney Diseases, in 2010 approximately 60 to 70 million people were affected by major or minor GI diseases. This number is continuously increasing due to poor diet and increasing aging population. The global GI series market is driven mainly by increasing prevalence of GI diseases & gastric cancer, and changing lifestyle. Developments in the technologies, cost-effective methods, increasing aging population and government support for research have also affected the growth of the market positively. Whereas, availability of alternative therapies and limited applications of the method have hampered the growth of the market.


Study Objectives of Global Upper Gastrointestinal (GI) Series Market



  • To provide a detailed information about drivers and factors restraining the market growth.

  • To provide the market growth map over the forecasted period 2017-2023

  • To provide detailed analysis of the market structure along with forecast for the next seven years of various segments and sub-segments of the global upper GI series

  • To provide the graphs and analyze the market on various factors like- Price Analysis, Supply Chain Analysis, Porters Five Force Analysis, etc.

  • To provide the trends and opportunities in global upper GI series

  • To provide historical and forecast revenue of the market segments and sub-segments with respect to main countries

  • To provide the overview of key players and their strategic profiles in the market and drawing a competitive landscape for the market


Figure 1- Global upper GI series market, by region

 upper GI series market


Sources- Annual reports, Press release, White paper, Company Presentation


 


Global GI series market is expected to grow at a CAGR of 4.5% during the forecast period 2017-2023.


Segmentation:


The global upper GI series market is segmented on the basis of test type, into standard barium upper GI series and double-contrast upper GI series. On the basis of imaging material, the market is segmented into: barium swallow, barium meal, and barium follow-through. On the basis of application, the market is segmented into: esophageal reflux, esophageal varices, ulcers, hiatal hernias, and others. On the basis of end users, it is segmented into: hospitals, clinics & laboratories, and other


Regional Analysis:


Owing to the presence of large patient population, well-developed medical sector, and increasing geriatric population, America accounts for the largest market for GI series. Europe is the second largest market, followed by Asia Pacific. Asia Pacific is the fastest growing market for upper GI series due to presence of many developing countries and cost effective method. However Middle East and Africa has the least market for the upper GI series.


Key Players for global upper GI series market:


GastroIntestinal Specialists LLC. (UK), Eisai Co., Ltd (Japan), Cadila Pharmaceuticals Limited (India), Purdue Pharma L.P. (US), Alfa Wassermann SPA (Germany), Novadaq Technologies Inc. (Canada), AstraZeneca (UK), Ironwood Pharmaceuticals Inc. (US) and others.


 Intended Audience



  • Manufacturing Industries

  • Pharmaceutical Industry

  • Biotechnology Companies

  • Research and Development (R&D) Companies

  • Government Research Laboratories

  • Medical Research Institutes


The report for global upper GI series market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   4.5% (2017-2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   test types, type of imaging material, application and end users
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   GastroIntestinal Specialists LLC. (UK), Eisai Co., Ltd (Japan), Cadila Pharmaceuticals Limited (India), Purdue Pharma L.P. (US), Alfa Wassermann SPA (Germany), Novadaq Technologies Inc. (Canada), AstraZeneca (UK), Ironwood Pharmaceuticals Inc. (US)
  Key Market Opportunities   increasing aging population and government support for research
  Key Market Drivers   increasing prevalence of GI diseases & gastric cancer, and changing lifestyle.


Frequently Asked Questions (FAQ) :


High incidence of GI diseases and changing lifestyles of patients are major drivers of the global upper gastrointestinal (GI) series market.

Development of diagnostic techniques and government support for research on GI diseases are prime opportunities for growth in the global gastrointestinal (GI) series market.

Alternative therapies and limited applications of current diagnostic methods can hamper the global upper gastrointestinal (GI) series market growth.

The Americas can dominate the global upper gastrointestinal (GI) series market till 2027.

Eisai Co., Ltd, Purdue Pharma L.P., AstraZeneca, Cadila Pharmaceuticals Limited, GastroIntestinal Specialists LLC, Alfa Wassermann SPA, Novadaq Technologies Inc., and Ironwood Pharmaceuticals Inc. are major players of the global upper gastrointestinal (GI) series market.

TABLE OF CONTENTS

1 INTRODUCTION

1.1 DEFINITION

1.2 SCOPE OF STUDY

1.2.1 RESEARCH OBJECTIVE

1.2.2 ASSUMPTIONS & LIMITATIONS

1.2.2.1 ASSUMPTIONS

1.2.2.2 LIMITATIONS

1.3 MARKET STRUCTURE:

2 RESEARCH METHODOLOGY

2.1 RESEARCH PROCESS:

2.2 PRIMARY RESEARCH

2.3 SECONDARY RESEARCH:

3 MARKET DYNAMICS

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 MACROECONOMIC INDICATORS

4 MARKET FACTOR ANALYSIS

4.1 PORTERS FIVE FORCES MODEL

4.2 BARGAINING POWER OF SUPPLIERS

4.3 BARGAINING POWER OF BUYERS

4.4 THREAT OF NEW ENTRANTS

4.5 THREAT OF SUBSTITUTES

4.6 INTENSITY OF RIVALRY


5. GLOBAL UPPER GI SERIES MARKET, BY TEST TYPE

5.1 STANDARD BARIUM UPPER GI SERIES

5.2 DOUBLE-CONTRAST UPPER GI SERIES

6. GLOBAL UPPER GI SERIES MARKET, BY IMAGING MATERIAL

6.1 BARIUM SWALLOW

6.2 BARIUM MEAL

6.3 BARIUM FOLLOW-THROUGH

7. GLOBAL UPPER GI SERIES MARKET, APPLICATION

7.1 ESOPHAGEAL REFLUX

7.2 ESOPHAGEAL VARICES

7.3 ULCERS

7.4 HIATAL HERNIAS

7.5 OTHERS

8 GLOBAL UPPER GI SERIES MARKET, BY END USERS

8.1 HOSPITALS

8.2 CLINICS & LABORATORIES

8.3 OTHER

9. GLOBAL UPPER GI SERIES MARKET, BY REGION

9.1 INTRODUCTION

9.2 AMERICA

9.2.1 NORTH AMERICA

9.2.1.1 US

9.2.1.2 CANADA

9.2.2 SOUTH AMERICA

9.3 EUROPE

9.3.1 WESTERN EUROPE

9.3.1.1 GERMANY

9.3.1.2 FRANCE

9.3.1.3 ITALY

9.3.1.3 SPAIN

9.3.1.5 UK

9.3.1.6 REST OF WESTERN EUROPE

9.3.2 EASTERN EUROPE

9.4 ASIA PACIFIC

9.4.1 JAPAN

9.4.2 CHINA

9.4.3 INDIA

9.4.4 AUSTRALIA

9.4.5 REPUBLIC OF KOREA

9.4.6 REST OF ASIA-PACIFIC

9.5 THE MIDDLE EAST & AFRICA

9.5.1 UNITED ARAB EMIRATES

9.5.2 SAUDI ARABIA

9.5.3 OMAN

9.5.4 KUWAIT

9.5.5 QATAR

9.5.6 REST OF MIDDLE EAST & AFRICA

10. COMPETITIVE LANDSCAPE

10.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS

10.1.1 STRATEGIC PARTNERSHIP

10.1.2 MERGER & ACQUISITION

11 COMPANY PROFILE

11.1 EISAI CO., LTD

11.1.1 OVERVIEW

11.1.2 PRODUCT OVERVIEW

11.1.3 FINANCIALS

11.1.4 KEY DEVELOPMENTS

11.2 CADILA PHARMACEUTICALS LIMITED

11.2.1 OVERVIEW

11.2.2 PRODUCT OVERVIEW

11.2.3 FINANCIALS

11.2.4 KEY DEVELOPMENTS

11.3 PEACEHEALTH

11.3.1 OVERVIEW

11.3.2 PRODUCT OVERVIEW

11.3.3 FINANCIALS

11.3.4 KEY DEVELOPMENT

11.4 PURDUE PHARMA L.P.

11.4.1 OVERVIEW

11.4.2 PRODUCT OVERVIEW

11.4.3 FINANCIALS

11.4.4 KEY DEVELOPMENTS

11.5 ALFA WASSERMANN SPA

11.5.1 OVERVIEW

11.5.2 PRODUCT OVERVIEW

11.5.3 FINANCIALS

11.5.4 KEY DEVELOPMENTS

11.6 NOVADAQ TECHNOLOGIES INC.

11.6.1 OVERVIEW

11.6.2 PRODUCT OVERVIEW

11.6.3 FINANCIALS

11.6.4 KEY DEVELOPMENTS

11.7 MOUNT SINAI BETH

11.7.1 OVERVIEW

11.7.2 PRODUCT OVERVIEW

11.7.3 FINANCIALS

11.7.4 KEY DEVELOPMENTS

11.8 ASTRAZENECA

11.8.1 OVERVIEW

11.8.2 PRODUCT OVERVIEW

11.8.3 FINANCIALS

11.8.4 KEY DEVELOPMENT

11.9 IRONWOOD PHARMACEUTICALS INC.

11.9.1 OVERVIEW

11.9.2 PRODUCT OVERVIEW

11.9.3 FINANCIALS

11.9.4 KEY DEVELOPMENT

11.10 OTHERS

12 CONCLUSION

12.1 KEY FINDINGS

12.1.1 FROM CEO’S VIEWPOINT

12.1.2 UNMET NEEDS OF THE MARKET

12.2 KEY COMPANIES TO WATCH

12.3 PREDICTION OF GASTROCARE INDUSTRY

13 APPENDIX


LIST OF TABLES

Table 1 Upper GI Series Industry Synopsis, 2020-2027

Table 2 Global Upper GI Series Market Estimates & Forecast, 2020-2027, (USD Million)

Table 3 Global Upper GI Series Market, by Region, 2020-2027, (USD Million)

Table 4 Global Upper GI Series Market, by Test Type, 2020-2027, (USD Million)

Table 5 Global Upper GI Series Market, by Imaging Material, 2020-2027, (USD Million)

Table 6 Global Upper GI Series Market, by Application, 2020-2027, (USD Million)

Table 7 Global Upper GI Series Market, by End-User, 2020-2027, (USD Million)

Table 8 North America Upper GI Series Market, by Test Type, 2020-2027, (USD Million)

Table 9 North America Upper GI Series Market, by Imaging Material, 2020-2027, (USD Million)

Table 10 North America Upper GI Series Market, by Application, 2020-2027, (USD Million)

Table 11 North America Upper GI Series Market, by End-User, 2020-2027, (USD Million)

Table 12 U.S. Upper GI Series Market, by Test Type, 2020-2027, (USD Million)

Table 13 U.S. Upper GI Series Market, by Imaging Material, 2020-2027, (USD Million)

Table 14 U.S. Upper GI Series Market, by Application, 2020-2027, (USD Million)

Table 15 U.S. Upper GI Series Market, by End-User, 2020-2027, (USD Million)

Table 16 Canada Upper GI Series Market, by Test Type, 2020-2027, (USD Million)

Table 17 Canada Upper GI Series Market, by Imaging Material, 2020-2027, (USD Million)

Table 18 Canada Upper GI Series Market, by Application, 2020-2027, (USD Million)

Table 19 Canada Upper GI Series Market, by End-User, 2020-2027, (USD Million)

Table 20 South America Upper GI Series Market, by Test Type, 2020-2027, (USD Million)

Table 21 South America Upper GI Series Market, by Imaging Material, 2020-2027, (USD Million)

Table 22 South America Upper GI Series Market, by Application, 2020-2027, (USD Million)

Table 23 South America Upper GI Series Market, by End-User, 2020-2027, (USD Million)

Table 24 Europe Upper GI Series Market, by Test Type, 2020-2027, (USD Million)

Table 25 Europe Upper GI Series Market, by Imaging Material, 2020-2027, (USD Million)

Table 26 Europe Upper GI Series Market, by Application, 2020-2027, (USD Million)

Table 27 Europe Upper GI Series Market, by End-User, 2020-2027, (USD Million)

Table 28 Western Europe Upper GI Series Market by Test Type, 2020-2027, (USD Million)

Table 29 Western Europe Upper GI Series Market, by Imaging Material, 2020-2027, (USD Million)

Table 30 Western Europe Upper GI Series Market, by Application, 2020-2027, (USD Million)

Table 31 Western Europe Upper GI Series Market, by End-User, 2020-2027, (USD Million)

Table 32 Eastern Europe Upper GI Series Market, by Test Type, 2020-2027, (USD Million)

Table 33 Eastern Europe Upper GI Series Market, by Imaging Material, 2020-2027, (USD Million)

Table 34 Eastern Europe Upper GI Series Market, by Application, 2020-2027, (USD Million)

Table 35 Eastern Europe Upper GI Series Market, by End-User, 2020-2027, (USD Million)

Table 36 Asia Pacific Upper GI Series Market, by Test Type, 2020-2027, (USD Million)

Table 37 Asia Pacific Upper GI Series Market, by Imaging Material, 2020-2027, (USD Million)

Table 38 Asia Pacific Upper GI Series Market, by Application, 2020-2027, (USD Million)

Table 39 Asia Pacific Upper GI Series Market, by End-User, 2020-2027, (USD Million)

Table 40 Middle East & Africa Upper GI Series Market, by Test Type, 2020-2027, (USD Million)

Table 41 Middle East & Africa Upper GI Series Market, by Imaging Material, 2020-2027, (USD Million)

Table 42 Middle East & Africa Upper GI Series Market, by Application, 2020-2027, (USD Million)

Table 43 Middle East & Africa Upper GI Series Market, by End-User, 2020-2027, (USD Million) 

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Upper GI Series Market

Figure 3 Segmentation Market Dynamics for Upper GI Series Market

Figure 4 Global Upper GI Series Market Share, by Test Type 2020

Figure 5 Global Upper GI Series Market Share, by Imaging Material 2020

Figure 6 Global Upper GI Series Market Share, by Application 2020

Figure 7 Global Upper GI Series Market Share, by End Users, 2020

Figure 8 Global Upper GI Series Market Share, by Region, 2020

Figure 9 North America Upper GI Series Market Share, by Country, 2020

Figure 10 Europe Upper GI Series Market Share, by Country, 2020

Figure 11 Asia Pacific Upper GI Series Market Share, by Country, 2020

Figure 12 Middle East & Africa Upper GI Series Market Share, by Country, 2020

Figure 13 Global Upper GI Series Market: Company Share Analysis, 2020 (%)